Absorbed dose after Lu-177-DOTATATE therapy and correlation analysis with Ga-68-DOTATOC PET/CT
Lesion | Number | Estimated absorbed dose of Lu-177-DOTATATE therapy | SUVmean of Ga-68-DOTATOC PET/CT | Spearman’s correlation coefficient | P-value |
Tumor (total) | 95 | 19.2 ± 16.1 Gy | 19.9 ± 11.4 | 0.77 | < 0.001* |
Hepatic metastasis | 60 | 24.3 ± 15.8 Gy | 23.0 ± 11.7 | 0.63 | < 0.001* |
Other tumor | 35 | 10.3 ± 12.4 Gy | 14.0 ± 8.0 | 0.87 | < 0.001* |
Critical organ (total) | 51 | 2.7 ± 2.5 Gy | 4.3 ± 3.1 | 0.62 | < 0.001* |
Kidney | 25 | 4.7 ± 1.7 Gy | 5.6 ± 2.7 | 0.46 | 0.022* |
Liver | 13 | 1.2 ± 1.2 Gy | 5.6 ± 1.8 | 0.49 | 0.090 |
Bone marrow | 13 | 0.2 ± 0.2 Gy | 0.4 ± 0.2 | 0.08 | 0.788 |